Rare Toxicities of CAR T-Cell Therapy: Cardiovascular, Hematopoietic and Other Infrequent Adverse Events
Chimeric antigen receptor (CAR) T-cell therapy has proven to be an effective treatment option for various hematological malignancies. Despite the enormous potential of CAR T-cell therapy, there are still challenges to be addressed, including the management of significant toxicities associated with t...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
THE HEALTHBOOK COMPANY LTD.
2024-06-01
|
| Series: | healthbook TIMES. Oncology Hematology |
| Online Access: | https://doi.org/10.36000/HBT.OH.2024.20.147 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|